The β-cell glucose toxicity hypothesis: Attractive but difficult to prove
Related Experiment Video
Updated: Oct 21, 2025

A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
Gordon C Weir1, Peter C Butler2, Susan Bonner-Weir1
1Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Abstract:
β cells in the hyperglycemic environment of diabetes have marked changes in phenotype and function that are largely reversible if glucose levels can be returned to normal. A leading hypothesis is that these changes are caused by the elevated glucose levels leading to the concept of glucose toxicity. Support for the glucose toxicity hypothesis is largely circumstantial, but little progress has been made in defining the responsible mechanisms. Then questions emerge that are difficult to answer. In the very earliest stages of diabetes development, there is a dramatic loss of glucose-induced first-phase insulin release (FPIR) with only trivial elevations of blood glucose levels. A related question is how impaired insulin action on target tissues such as liver, muscle and fat can cause increased insulin secretion. The existence of a sophisticated feedback mechanism between insulin secretion and insulin action on peripheral tissues driven by glucose has been postulated, but it has been difficult to measure increases in blood glucose levels that might have been expected. These complexities force us to challenge the simplicity of the glucose toxicity hypothesis and feedback mechanisms. It may turn out that glucose is somehow driving all of these changes, but we must develop new questions and experimental approaches to test the hypothesis.
Insights
High blood glucose in diabetes alters beta cell function, but mechanisms remain unclear. New research questions the simple glucose toxicity hypothesis, suggesting complex feedback loops may be involved.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Cell Biology
Background:
- Diabetes mellitus is characterized by hyperglycemia, leading to significant changes in pancreatic beta cell phenotype and function.
- These beta cell alterations are often reversible with normalization of glucose levels, supporting the concept of glucose toxicity.
- However, the precise molecular mechanisms underlying glucose toxicity and its impact on beta cells are not well-defined.
Purpose of the Study:
- To investigate the mechanisms by which elevated glucose levels affect pancreatic beta cell function in diabetes.
- To critically evaluate the prevailing glucose toxicity hypothesis in light of early diabetes development.
- To explore potential complex feedback mechanisms between insulin secretion and insulin action.
Main Methods:
- The study reviews existing literature and postulates new experimental approaches to investigate beta cell dysfunction in diabetes.
- Focuses on analyzing the early stages of diabetes, particularly the loss of first-phase insulin release (FPIR).
- Examines the relationship between impaired insulin action in peripheral tissues and compensatory insulin secretion.
Main Results:
- Observed a significant loss of glucose-induced first-phase insulin release (FPIR) in the early stages of diabetes, even with minimal blood glucose elevation.
- Identified complexities in understanding how impaired insulin action on target tissues might lead to increased insulin secretion.
- Highlighted difficulties in measuring expected blood glucose level increases, challenging simple feedback models.
Conclusions:
- The simplicity of the glucose toxicity hypothesis and basic feedback mechanisms may not fully explain the observed complexities in diabetes pathophysiology.
- Further research with novel experimental strategies is required to elucidate the intricate relationship between glucose, beta cell function, and insulin action.
- Glucose may indeed drive these changes, but the underlying mechanisms necessitate a re-evaluation and development of new hypotheses.
More Related Videos
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational

